Day: April 1, 2024

NewtekOne, Inc. Announces Loan Closings for the First Quarter 2024

Written by Customer Service on April 1, 2024. Posted in Public Companies.

Record Loan Approvals Across All Loan Products in First Quarter 2024 Strong Growth in Lending and Deposits in the First Quarter 2024 BOCA RATON, Fla., April 01, 2024 (GLOBE NEWSWIRE) — NewtekOne, Inc. (the “Company” or “NewtekOne”) (NASDAQ: NEWT), announced today that its nationally chartered bank subsidiary, Newtek Bank, N.A., closed $207.7 million of SBA 7(a) loans for the three months ended March 31, 2024, which represents a 36.2% increase over $152.5 million of SBA 7(a) loans closed in the first quarter 2023. Newtek Bank and the Company’s non-bank subsidiaries closed $308.6 million of loans, across all loan products, for the three months ended March 31, 2024, which represents a 35.8% increase over $227.2 million for the same period in 2023. The Company also announced strong growth in its loan approval pipeline across all lending...

NewtekOne, Inc. Promotes Frank M. DeMaria to Chief Accounting Officer

Written by Customer Service on April 1, 2024. Posted in Public Companies.

BOCA RATON, Fla., April 01, 2024 (GLOBE NEWSWIRE) — NewtekOne, Inc. (the “Company”) (NASDAQ: NEWT) has promoted Mr. Frank M. DeMaria to Executive Vice President, Chief Accounting Officer of NewtekOne effective as of March 29, 2024. Mr. DeMaria has been with NewtekOne since May of 2023 as Senior Vice President of Accounting and Finance. Frank brings a career’s worth of experience across many facets of financial holding company accounting and finance to this position. Frank’s prior experience includes being Senior Vice President & Controller at Flagstar Bank, N.A; Senior Vice President & Chief Accounting Officer at Amalgamated Financial Corp.; and Senior Manager at KPMG LLP, Audit Financial Services. Frank will report to M. Scott Price, Chief Financial Officer of NewtekOne. Our former Chief Accounting Officer, Nick Leger,...

CORRECTING and REPLACING NewtekOne, Inc. News Release

Written by Customer Service on April 1, 2024. Posted in Earnings Releases And Operating Results.

BOCA RATON, Fla., April 01, 2024 (GLOBE NEWSWIRE) — Today NewtekOne, Inc. (“NewtekOne”) timely filed its annual report on Form 10-K for the period ended December 31, 2023. The purpose of this press release is to update and replace NewtekOne’s press release dated March 5, 2024, which announced NewtekOne’s unaudited fourth quarter and full year 2023 financial results. NewtekOne, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results Full Year 2023 Basic Earnings per Share of $1.89 and Diluted Earnings per Share of $1.88 NewtekOne, Inc. (Nasdaq: NEWT), announced today its audited financial and operating results for the three and twelve months ended December 31, 2023. This is NewtekOne’s fourth quarter reporting, and third full quarter reporting, as a financial holding company following the Company’s January...

SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers

Written by Customer Service on April 1, 2024. Posted in Public Companies.

CHINO HILLS, Calif., April 01, 2024 (GLOBE NEWSWIRE) — via IBN — SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the collaboration with Coastar Therapeutics, San Diego, California, a leading biotechnology company specializing in innovative drug delivery systems, and SOHM, a cutting-edge biopharmaceutical company focused on gene editing technologies, are excited to announce their collaboration to advance the field of genome editing using Coastar’s red blood cell membrane derived carriers and SOHM’s ABBIE (A Binding Based Integrase Enzyme) genome editing technology. Genome editing, particularly through the use of CRISPR-Cas9 technology, has emerged as a groundbreaking approach...

APA Corporation Appoints Matthew Bob and Anya Weaving to Board of Directors

Written by Customer Service on April 1, 2024. Posted in Public Companies.

HOUSTON, April 01, 2024 (GLOBE NEWSWIRE) — APA Corporation (Nasdaq: APA) today announced the appointment of Matthew Bob and Anya Weaving to its board of directors. “We are very pleased to welcome Matthew and Anya to the APA board,” said Lamar McKay, APA’s nonexecutive board chair. “Matthew brings extensive executive and operational experience with U.S. onshore oil and gas companies in addition to his technical expertise. His knowledge of Callon will provide the board with valuable insight and guidance on the newly acquired company assets. Anya’s experience in the oil and gas industry as well as her background advising large cap energy companies will bring additional critical skills to the board. Her expertise in mergers and acquisitions and other financial transactions will support the board in evaluating future strategic opportunities....

APA Corporation Completes Acquisition of Callon Petroleum Company

Written by Customer Service on April 1, 2024. Posted in Mergers And Acquisitions.

HOUSTON, April 01, 2024 (GLOBE NEWSWIRE) — APA Corporation (NASDAQ: APA) announced today that its acquisition of Callon Petroleum Company (NYSE: CPE) has been completed. The transaction was approved by APA and Callon shareholders at special meetings held on March 27, 2024. “We are very pleased to close this transaction as Callon’s assets bring scale to our Delaware position and balance to our overall Permian asset base — all at what we believe is a compelling valuation,” said John J. Christmann IV, APA’s CEO. “We are confident this transaction will create shareholder value, as we expect to drive improved capital productivity and well performance, while realizing significant cost synergies. We look forward to applying our technical expertise and work processes across the Callon acreage to unlock potentially substantial shareholder...

First Busey Corporation Finalizes Acquisition of Merchants and Manufacturers Bank Corporation and Merchants and Manufacturers Bank

Written by Customer Service on April 1, 2024. Posted in Mergers And Acquisitions.

CHAMPAIGN, Ill. and OAKBROOK TERRACE, Ill., April 01, 2024 (GLOBE NEWSWIRE) — First Busey Corporation (“Busey”) (NASDAQ: BUSE), the holding company for Busey Bank, announced the completion of its acquisition of Merchants and Manufacturers Bank Corporation (“M&M”), the holding company for Merchants and Manufacturers Bank (“M&M Bank”), effective April 1, 2024. The transaction was previously announced on November 27, 2023. At the effective time of the merger, each share of M&M common stock converted to the right to receive, at the election of each shareholder, and subject to proration and adjustment as provided in the merger agreement, (i) $117.74 in cash, (ii) 5.7294 shares of Busey common stock, or (iii) mixed consideration of $34.55 in cash and 4.0481 shares of Busey common stock, with total consideration consisting...

Reading International Reports Fourth Quarter and Full Year 2023 Results

Written by Customer Service on April 1, 2024. Posted in Earnings Releases And Operating Results.

Earnings Call Webcast to Discuss 2023 Fourth Quarter and Full Year Financial Results Scheduled to Post to Corporate Website on Wednesday, April 3, 2024 NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) — Reading International, Inc. (NASDAQ: RDI) (“Reading” or our “Company”), an internationally diversified cinema and real estate company with operations and assets in the United States, Australia, and New Zealand, today announced its results for the fourth quarter and year ended December 31, 2023. Full Year 2023 Summary compared to 2022 Notwithstanding the Writers and Actors strikes (the “2023 Hollywood Strikes”) that effectively shut down Hollywood for months in 2023 and a 525-point spike in interest rates since March 2022, new movie releases are being well received by movie patrons and, generally speaking, things are moving in the right...

Biomea Fusion Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights

Written by Customer Service on April 1, 2024. Posted in Earnings Releases And Operating Results.

In 2023, reported Phase 2 data (COVALENT-111) in type 2 diabetes patients supporting the disease-modifying potential of BMF-219 to address a root cause of diabetes: a loss of healthy, insulin-producing beta cells.After just a 4-week treatment period in type 2 diabetes patients, who had previously failed standard of care (HbA1c > 7.0% and < 10%), BMF-219 demonstrated continued glycemic control at 26 weeks, or five months, after cessation of dosing. Enrollment underway in COVALENT-111 expansion cohort (n=216) to evaluate dosing duration up to 12 weeks; initial readout after 26 weeks of follow up expected in 2024.In 2023, initiated a Phase 2 study of BMF-219 in type 1 diabetes patients (COVALENT-112); initial readout anticipated in 2024. Biomea aims to deliver short-term, non-chronic treatment that will reconstitute insulin-producing...

Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Medical Officer

Written by Customer Service on April 1, 2024. Posted in Public Companies.

BETHESDA, Md., April 01, 2024 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation allosteric small molecule therapies, today announces the appointment of Jonas Hannestad, M.D., Ph.D. as its chief medical officer, effective as of March 25, 2024. “I am pleased to welcome Jonas to Gain and look forward to his contributions. His extensive development experience and in-depth scientific background in Parkinson’s and other neurodegenerative diseases will be invaluable as we advance our GT-02287 program through the ongoing Phase 1 clinical trial into further clinical development,” commented Gain CEO Matthias Alder. Dr. Hannestad has 25 years of translational and early clinical development experience in CNS....

Day: April 1, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice